How Long Does Perimenopause Last? The Real Timeline, Stage by Stage
By The HRT Index Editorial Team · Last verified August 2026
Educational research, not medical advice. This page has not been reviewed by a clinician — see our medical review policy.
How long does perimenopause last? About four years before periods stop for most women, with a federal range of two to eight years. Menopause is confirmed after 12 months with no bleeding or spotting. STRAW+10 uses a broader “perimenopause” window that includes that confirmation year, so some timelines are one year longer.
This timeline is most useful if: you have natural bleeding you can roughly track, and no medication, procedure, or condition is masking your cycle pattern.
Don't rely on period-counting if: you've had a hysterectomy or endometrial ablation, you have PCOS, hormonal birth control or a hormonal IUD has changed your bleeding, you're taking hormone therapy, you're under 40 and your periods stopped, or cancer treatment or another illness is affecting your cycles. We cover what to do instead in “When the timeline doesn't apply to you.”
| The number | What it means |
|---|---|
| ~4 years | Average time in perimenopause before periods stop, under current Office on Women's Health guidance |
| 2–8 years | Federal range before periods stop |
| 7 days | Persistent cycle-length difference that marks the early menopausal transition |
| 60 days | Period-free interval that marks the late menopausal transition |
| 12 months | No bleeding or spotting — menopause is confirmed; STRAW+10 includes this year in its broad use of “perimenopause” |
| 52 | Average U.S. age at menopause; usual range 45–58 |
Sources: Office on Women's Health, STRAW+10, and longitudinal menopausal-transition research.
Before you read another number: the honest limit
No website, no calculator, and no blood test can tell you the exact date of your final period. Not ours. Not anyone's.
We're saying that up front because you're about to read a lot of specific figures, and you deserve to know what they can and can't do. They're population averages and medians. They describe what happened across groups of women in long-running studies. They don't predict you.
But here's what they can do, and it's more than you've probably been offered so far: your cycle pattern can show which broad stage you resemble, which research range applies, and what the numbers actually measure. That's not a prophecy. It's a map with a “you are here” dot on it — and after months of being handed a shrug and a four-year average, a map is worth a lot.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
How long does perimenopause last on average?
Perimenopause lasts about four years before periods stop for most women, and current federal guidance gives a range of two to eight years. That answer uses the Office on Women's Health definition: the transition leading up to the final period. Menopause is then confirmed only after 12 consecutive months with no bleeding or spotting.
That's the direct answer. Now the useful part.
The four-year figure is real, and it's federal. The Office on Women's Health — part of the U.S. Department of Health and Human Services — says the transition can last two to eight years before periods stop permanently and lasts about four years for most women. Its current page was updated April 2, 2026.
But if you've been searching this question for a while, you've noticed something odd: that number doesn't match what you read on the last site. Or the one before that.
You're not imagining it.
The numbers, with their start and stop points exposed
We rebuilt the answer from primary sources and put every major clock in the same table. This is the comparison that matters, because a number without a start point and an end point is almost useless.
| Evidence source | Published number | Where its clock starts | Where its clock stops | What it can tell you | What it cannot tell you |
|---|---|---|---|---|---|
| Office on Women's Health | 2–8 years; about 4 for most | The transition leading up to the last period | Final menstrual period | The clean headline answer | Symptom duration or the extra confirmation year |
| STRAW+10 | Late stage has an estimated duration of 1–3 years | First interval of 60+ days without a period | Final menstrual period | The consensus duration of the late transition | Your exact final-period date |
| Harlow 2018 review | 5–8 years after age 40 | Persistent 7+ day difference between consecutive cycle lengths | Final menstrual period | The median runway from the early-stage marker | A fixed duration for early Stage −2 itself |
| Harlow 2018 review | 2.5–3 years after age 40 | First 60+ day period-free interval | Final menstrual period | The median runway from the late-stage marker | A personal countdown |
| SWAN duration study | 4.37–8.57 years | Onset of the bleeding-defined transition | Final menstrual period | How strongly age at onset shifts group medians | What one woman's duration will be |
| SWAN symptom study | 7.4 years total; 4.5 after the final period | First report of frequent hot flashes or night sweats | End of frequent symptoms | Why symptoms can outlast periods by years | The length of perimenopause itself |
Evidence grid assembled and reverified August 3, 2026 from the cited primary sources.
Six evidence blocks. Six numbers. They are not really arguing with each other — they're timing different starting points, different stopping points, or a different thing altogether.
Once you know which clock a number came from, the confusion disappears.
Why does every website give a different number?
Published estimates differ because “how long” can refer to four separate clocks: the years before the final period, the broader STRAW+10 window that includes the 12-month confirmation year, the time from a specific cycle marker, or the symptom timeline. A fifth source of variation is age at onset: earlier transitions last longer at the group level.
There are several clocks running at once. Most pages hand you a number without labeling which one they started.
Clock 1 — the federal transition clock. The Office on Women's Health defines perimenopause as the time leading up to the final period. On that clock, federal guidance gives a range of two to eight years and an average of about four.
Clock 2 — the broader STRAW+10 perimenopause clock. STRAW+10 uses “perimenopause” in the common around-menopause sense: it begins at early Stage −2 and ends 12 months after the final menstrual period. That definition runs one year beyond the final period.
Clock 3 — the marker clock. A persistent seven-day cycle difference and a 60-day period-free interval are research markers with their own median times to the final period. Those figures are five to eight years and about 2.5 to 3 years, respectively, after age 40.
Clock 4 — the symptom clock. Frequent hot flashes and night sweats can start before obvious period changes and continue for years afterward. That clock is longer than the bleeding-defined transition for many women.
The modifier — age at onset. In SWAN, the adjusted median transition was 8.57 years in the youngest age-at-onset quartile and 4.37 years in the oldest. Those are group medians, not personal forecasts.
The averages you've read lean toward later starters
A reanalysis of the decades-long Treloar menstrual-diary data separated women into six groups by when the transition began and how it unfolded. Four groups began around age 40. Two began much later, around age 46.5.
The average duration for the two later-starting groups — plus one early-starting group — was six years.
For the other three early-starting groups, it was nine to 11 years.
Then comes the line that reframes the four-year answer: because many midlife cohort studies enrolled women by age, they mostly captured the two later-starting groups, which represented about one-third of women in that reanalysis.
Read that again, because it's the answer to a question you may have been quietly asking yourself.
If you started early — late 30s or early 40s — and the four-year average has never matched your experience, a long course can still fit the published pattern. That does not prove every symptom is caused by perimenopause, but it does mean the calendar alone is not evidence that your body is broken.
What stage of perimenopause am I in?
Your cycle pattern usually places you better than your symptoms do. A persistent difference of seven or more days between consecutive cycle lengths marks the early transition; a period-free interval of 60 days or more marks the late transition. Menopause is confirmed only after 12 straight months with no bleeding or spotting.
These aren't rules of thumb we invented. They're the criteria from the Stages of Reproductive Aging Workshop +10 — STRAW+10 — the consensus framework used to stage reproductive aging. It treats menstrual criteria as primary and biomarkers as supportive, not required.
Here's what your calendar can tell you.
Stage −2: early transition — cycles varying by 7+ days
The marker: a persistent difference of seven or more days between consecutive cycle lengths. A 27-day cycle followed by a 35-day cycle qualifies as one variable cycle. “Persistent” has a technical meaning: the pattern recurs within 10 cycles. One strange month is not the marker. A pattern is.
How long it lasts: STRAW+10 does not assign one average duration to early Stage −2. It defines the entry marker but does not publish a fixed stage length.
That absence matters. It is one reason a clean four-year answer can feel almost insulting when you're already four years in.
There is still a useful longitudinal figure: after age 40, the median time from the persistent seven-day marker to the final menstrual period is five to eight years.
Five to eight years is a wide window. It's also a far more honest number for this stage than pretending every woman gets four years from first symptom to finish.
Stage −1: late transition — your first 60-day gap
The marker: one interval of 60 days or more without a period.
How long it lasts: STRAW+10 gives late Stage −1 an estimated duration of one to three years. In longitudinal evidence reviewed by Harlow, the median time after age 40 from the first 60-day interval to the final period was approximately 2.5 to 3 years.
This is the closest thing the research gives you to a countdown. It is tied to something you can check on a calendar. It is still a population median, not a date circled in red.
Two details worth having:
- In about one-third of women, the first 60-day interval is actually at least 90 days. Three months is not automatically an outlier.
- If you're under 45, one long interval may not classify the stage cleanly. Harlow's review says a repeated 60-day episode may help distinguish late transition from temporary amenorrhea related to stress. Pregnancy and concerning bleeding still need their own evaluation.
The final period and the confirmation year
Your final period is only ever named backward. You cannot know it's the last one while it's happening.
Then comes the definition split that causes so much confusion. The Office on Women's Health describes perimenopause as the years leading up to the final period. STRAW+10 uses the broader common term “perimenopause” through the first 12 months after it.
So two sources can differ by exactly one year without either one making a mathematical mistake.
The countdown, without hiding the arithmetic
| Stage marker | Published median or average to final period | Approximate time to the end of broad STRAW+10 “perimenopause” |
|---|---|---|
| Persistent 7+ day cycle difference | 5–8 years after age 40 | 6–9 years, adding the 12-month confirmation year |
| First 60+ day period-free interval | 2.5–3 years after age 40 | 3.5–4 years, adding the 12-month confirmation year |
| Final menstrual period | Identified only in hindsight | 12 months with no bleeding or spotting |
| 12 months with no bleeding or spotting | Menopause confirmed | Broad STRAW+10 perimenopause has ended |
The “broad STRAW+10” column is transparent arithmetic: the cited marker-to-final-period median plus the 12-month confirmation year. It is not a separately measured forecast.
What this means for you: if you've had your first 60-day interval, the group median puts the final period roughly 2.5 to 3 years away. Under the broader STRAW+10 use of the word, the end of perimenopause is roughly 3.5 to 4 years away.
Averages. Not promises. But it's a real number tied to something you can actually check on a calendar, and that's more useful than a floating range with no start point.
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
### You know your stage. Now find what fits it. Knowing where you are is step one. What to do about it depends on details this page cannot see — and the tool will tell you when online care is the wrong first move. Use Find My HRT Path — about 90 seconds, no email →
Does perimenopause last longer if it starts early?
Yes at the group level, and age at onset was the strongest measured predictor in the SWAN duration analysis. The adjusted median transition was 8.57 years in the youngest age-at-onset quartile and 4.37 years in the oldest — almost a twofold difference, without turning either number into a personal deadline.
| When the bleeding-defined transition began | Adjusted median duration to the final menstrual period |
|---|---|
| Youngest age-at-onset quartile | 8.57 years |
| Oldest age-at-onset quartile | 4.37 years |
Paramsothy et al., SWAN cohort, 1,145 women.
The women in the youngest-onset group had a longer early stage, a longer late stage, and a longer transition overall. The Treloar reanalysis points in the same direction: three early-starting groups averaged nine to 11 years.
If you started in your late 30s or early 40s, we're not going to soften this. The population data favor a longer transition.
But sit with what that actually means, because it isn't only bad news. It's the strongest practical argument for discussing symptom treatment now instead of waiting for the whole transition to finish. “Wait and see” is one proposition for six months. It's a genuinely different proposition at eight or nine years.
That doesn't make hormone therapy or any other treatment right for you. That's a clinician's decision with you. It makes the question worth asking now, rather than postponing it until life gets bad enough to earn attention.
What about smoking?
Here's a finding that gets left out of almost every article because it's awkward: smoking is associated with an earlier menopause and, in SWAN, an earlier start and shorter transition.
A shorter transition here is not a shortcut. The Office on Women's Health says smoking can bring menopause on up to two years earlier. That means reaching the low-estrogen postmenopausal years sooner, not finding a clever way around perimenopause.
That's not a win. It's just a different curve.
We include it because it's true and because leaving it out means someone else will eventually hand it to you without the part that matters.
What doesn't reliably predict your personal timeline
- Your mother's age at menopause. Federal guidance lists it as one clue. It is background, not a countdown.
- Body weight. The SWAN analysis found BMI was associated with later onset, but not with transition duration. Other evidence on onset is mixed.
- Number of pregnancies. The Office on Women's Health says pregnancy, especially more than one, may delay menopause. It still cannot give you a date.
- Symptoms alone. Hot flashes can be common in late transition without predicting how close the final period is.
We'd rather tell you what the evidence cannot do than hand you a confident number we cannot defend.
How will I know when perimenopause is over?
Menopause is confirmed after 12 consecutive months with no bleeding or spotting. Under federal wording, perimenopause is the transition before the final period; under STRAW+10's broader common usage, it ends when that 12-month confirmation year is complete. Either way, you only know the final period in hindsight.
The rule is simple, and the details are where people get tripped up.
Spotting counts. The Office on Women's Health is specific: menopause requires 12 months with no bleeding, including spotting. A day of light spotting at month nine means the confirmation count starts again from that most recent bleeding.
A period after a long gap is not your body reversing course. Periods may stop for months and return during the transition. It means the 12-month confirmation interval has not yet been completed.
And one more thing, which we're including carefully. Harlow's review notes that another menstrual bleed can occur after 12 months of amenorrhea in up to 10% of women, especially among women who reach that milestone younger.
That is a fact about study populations. It is not permission to wait and see. The Office on Women's Health says any vaginal bleeding after menopause should be evaluated as soon as possible. Both things can be true: some late bleeding reflects ovarian activity, and some has another cause that needs attention. You cannot sort those apart from home.
If you've gone 12 clear months and then bleed — even lightly, even once — get it looked at promptly. Don't let a statistic talk you out of an appointment.
What age does this usually happen?
The current Office on Women's Health figure is 52 for the average age of menopause in the United States, with a usual range of 45 to 58.
If you're 54 and still bleeding, you are inside that stated age range. That does not make every bleeding pattern normal; new, heavy, prolonged, or otherwise unusual bleeding still deserves review.
How long do perimenopause symptoms last?
Symptoms can last longer than the bleeding-defined transition. In SWAN, 1,449 women with frequent hot flashes or night sweats had a median total symptom duration of 7.4 years; among 881 with an observed final period, frequent symptoms persisted a median 4.5 years afterward. Those figures do not describe every woman or every symptom.
This is the question most women are really asking. You don't actually care which research stage owns month 43. You care when you stop waking up drenched at 3 a.m.
Different clock. Longer clock.
| What SWAN measured | Median |
|---|---|
| Total duration of frequent hot flashes and night sweats | 7.4 years |
| Persistence of frequent symptoms after the final period | 4.5 years |
| Symptoms beginning before period changes or in early transition | More than 11.8 years total; 9.4 years after the final period |
| Symptoms beginning after menopause | 3.4 years total — the shortest onset group |
Avis et al., SWAN. “Frequent” meant hot flashes or night sweats on at least six days in the previous two weeks.
The Office on Women's Health frames the same reality differently: hot flashes may continue for an average of nine years and may last up to 14.
That's where a frightening “14 years” can enter this conversation. It is a symptom clock, not a statement that you'll have irregular periods for 14 years.
The pattern that predicts a longer run
Look at the SWAN table again. The women whose frequent symptoms started before obvious period changes or in early transition had the longest run. Women whose frequent symptoms began after menopause had the shortest.
When frequent hot flashes or night sweats began was the strongest signal in that analysis for how long they lasted.
SWAN also found associations between longer frequent-symptom duration and younger age, lower educational level, greater perceived stress, greater symptom sensitivity, and higher depressive symptoms or anxiety when frequent symptoms were first reported.
Those are associations, not proof that stress, anxiety, education, or anything you did caused the symptoms or made them last longer. This is not your fault.
What “just wait it out” actually costs
Let's do the arithmetic, because this should change how you think about the next appointment.
If frequent hot flashes or night sweats began before your periods changed or during early transition, the study median was more than 11.8 years, with 9.4 years after the final period in that onset group.
Waiting it out is a reasonable answer to a six-month problem.
It's a very different answer to a decade.
That does not mean treatment is right for you. It means “come back when it's worse” deserves a follow-up question, not a nod.
### If waiting it out just got less appealing, find out what fits you. Treatment during perimenopause is not one-size-fits-all. Your bleeding pattern, contraception needs, risk history, state, and medication route can change the answer. See what fits your situation with Find My HRT Path → About 90 seconds. No email. It also flags when you should start in person.
Can a blood test tell me how much longer perimenopause will last?
No. Hormone levels can swing sharply during perimenopause, so a single FSH or estradiol result cannot stage you reliably or predict your final period. In SWAN and the Melbourne Women's Midlife Health Project, a 60-day period-free interval predicted proximity to the final period better than one early-follicular FSH result.
If you've been told your bloodwork was normal and sent home, this section is for you.
Your calendar beats one blood test — and that's from the research, not us
In both SWAN and the Melbourne Women's Midlife Health Project, an interval of 60 days or more without a period was a better predictor of proximity to the final menstrual period than a single early-follicular-phase serum FSH level.
Your period tracker can be more informative for broad staging than one blood draw. Nobody should have to learn that after paying for a panel that was treated like a verdict.
Why one FSH result can't stage you
STRAW+10 explains the problem. During the late transition, FSH can be elevated into a menopausal range at one point and fall into a range seen earlier in reproductive life at another, particularly alongside high estradiol. The framework treats biomarkers as supportive rather than required.
The Office on Women's Health says clinicians generally do not recommend hormone testing unless there is a medical reason, because hormone levels rise and fall unpredictably and make it difficult to tell whether someone has completed or is nearing menopause.
What the medication label does — and does not — prove
Current FDA-approved estradiol gel labeling states that serum FSH and estradiol levels are not useful for managing moderate-to-severe vasomotor symptoms.
That label statement is about treatment management, not a diagnostic rule for every patient. It does not say that testing is never useful. It does reinforce the larger point from federal guidance and STRAW+10: chasing one hormone number is not a reliable way to manage symptoms or produce a personal menopause countdown.
So if you were told a single “normal” hormone result proves your symptoms cannot be perimenopause, that conclusion outruns what these sources support.
You are allowed to bring that distinction to an appointment.
When testing does make sense
Clinical testing — not necessarily FSH — can be appropriate when:
- Your periods stopped or became markedly irregular before age 40
- Your age or symptoms are atypical
- Pregnancy, thyroid disease, anemia, or another condition needs consideration
- You have no usable bleeding signal because of surgery or treatment
- A clinician is evaluating abnormal bleeding
- A clinician is assessing possible primary ovarian insufficiency or another specific diagnosis
The point is not that testing is useless. It's that testing cannot answer this particular question, and “your labs are normal” is not a duration forecast.
What are the signs perimenopause is ending?
Longer gaps between periods are the most useful forward-looking clue, especially an interval of 60 days or more. Hot flashes, a good month, a bad month, age alone, and one FSH result are not dependable countdowns. Menopause is confirmed only after 12 months without bleeding or spotting.
Almost everyone gets this wrong, including a lot of articles.
Hot flashes getting worse are not a countdown
Harlow's review found that hot flashes, although common in late transition, did not predict proximity to the final period without information about amenorrhea and FSH.
Your symptoms might intensify near the end. They might ease. They might do both in the same season. None of that puts a date on the final period.
We know that's not what you wanted to hear. But if you've been reading tea leaves in your own symptoms — trying to decide whether a brutal month means you're close — you can stop spending energy on a signal that cannot carry that weight.
The clue that actually works
Longer gaps. That's the useful clue. Cycles stretch out, a 60-day interval appears, and longer intervals may follow.
| What you noticed | How useful is it? |
|---|---|
| Cycles persistently differing by 7+ days | Useful — early-transition marker |
| One interval of 60+ days | Useful — late-transition marker; median 2.5–3 years to the final period after age 40 |
| 12 months with no bleeding or spotting | Definitive for confirming menopause when no treatment or condition is masking the pattern |
| Hot flashes getting worse | Not a reliable countdown clue |
| A stretch where you feel fine | Not a reliable countdown clue |
| One FSH blood test | Less predictive than the 60-day calendar marker |
| Your age alone | Context only |
And for some women, there's no cycle warning at all
About 12% to 25% of women in the evidence reviewed by Harlow had minimal or no cycle-length change before the final period.
One clinical study found 12% experienced sudden amenorrhea. Two reanalyses of the Treloar diary data found about 15% and about 25% with minimal or no change in cycle length or variability before the final period.
So as many as a quarter of women may get little cycle-based runway. If your periods have stayed stubbornly regular while you've had hot flashes and wrecked sleep for two years, the pattern does not prove you're imagining it. It means cycle staging may not announce itself clearly for you.
That's a real limitation of everything on this page, and you deserved to know it before spending an hour trying to classify yourself.
Why does perimenopause feel so much longer than the numbers say?
Because the transition is not a steady hormone decline. Ovulatory and anovulatory cycles can alternate for years, so symptoms arrive, disappear, and return. A four-year average can contain several distinct waves, each convincing you that it is either finally over or starting all over again.
There's a mechanism behind the strangeness, and knowing it helps.
Researchers tracking ovulation found that 95% of women aged 40 to 55 with no recent cycle-length change ovulated consistently, compared with 34% of women who had recently experienced cycles longer than 35 days. The proportion of ovulatory cycles began declining roughly five years before the final menstrual period; within one year of it, 22.8% of cycles were ovulatory.
Whole-cycle hormone levels, meanwhile, remained relatively stable until roughly three years before menopause in the research summarized by Harlow.
Translate that: for years, your body can alternate between cycles that look hormonally ordinary and cycles that do not. Not a slope. A flicker.
That's why you get two good months and think it's over, then a terrible six weeks. It's why the symptom you finally got a handle on comes back. It's why the tidy phrase “about four years” can feel nothing like the life you're living.
That flickering is a common shape of the transition. It does not rule out another cause when symptoms or bleeding are new, severe, or don't fit your usual pattern.
When should bleeding during perimenopause be checked?
Irregular bleeding is common, but very heavy bleeding, bleeding longer than seven days, bleeding between periods, or cycles usually less than 21 days apart should be discussed with a clinician. Any bleeding after menopause has been confirmed — after 12 clear months — needs prompt evaluation rather than a timeline guess.
The fact that heavy and prolonged bleeding can occur during the transition does not mean every bleeding pattern should be filed under “just perimenopause.”
| Bleeding pattern | What to do |
|---|---|
| Very heavy bleeding | Seek prompt medical care. Urgent evaluation may be appropriate if you bleed through one or more pads or tampons every one to two hours, or feel dizzy, lightheaded, weak, have chest pain, or have trouble breathing |
| Bleeding longer than seven days | Arrange clinical review |
| Bleeding between periods | Arrange clinical review |
| Cycles usually less than 21 days apart | Arrange clinical review |
| Bleeding after sex | Arrange clinical review |
| Any bleeding after 12 months with none | Seek prompt evaluation; postmenopausal bleeding is not considered normal |
Mayo Clinic lists very heavy bleeding, bleeding longer than seven days, bleeding between periods, and periods usually less than 21 days apart as reasons to see a clinician. Mayo also advises evaluation of ongoing bleeding after sex. The Office on Women's Health lists bleeding through products every one to two hours or bleeding with dizziness, weakness, chest pain, or trouble breathing as reasons to seek care, and advises prompt review of any postmenopausal bleeding.
Depending on the pattern, age, and risk history, an abnormal-bleeding workup may involve an in-person pelvic examination, imaging, or endometrial sampling. Current FDA estrogen labeling also directs clinicians to use diagnostic measures, including endometrial sampling when indicated, for abnormal genital bleeding of unknown cause. A video visit cannot physically perform those procedures.
Do not use the 2.5-to-3-year median to explain away bleeding that needs its own evaluation.
When the timeline doesn't apply to you
If surgery, medication, or another condition has changed your bleeding pattern, the standard calendar cannot stage you cleanly. STRAW+10 specifically says menstrual criteria do not work after hysterectomy or endometrial ablation or with PCOS, and cancer treatment, tamoxifen, chronic illness, and hormonal medication can make bleeding or hormone markers misleading.
Every simple timeline uses bleeding as its clock. Almost none of them tell you when that clock has stopped being readable.
| Your situation | Why period-counting fails | What to do instead |
|---|---|---|
| Hysterectomy or endometrial ablation | There may be no reliable bleeding pattern | Clinical history and supportive hormone criteria may help. STRAW+10 recommends waiting at least three months after pelvic surgery before assessing endocrine status; one FSH/estradiol sample can mislead and may need repeating. |
| Hormonal IUD, pill, patch, ring, or continuous contraception | Bleeding may reflect the medication rather than ovarian stage | Use age, symptoms, treatment history, contraception needs, and clinician guidance instead of applying the 60-day or 12-month rules mechanically. |
| Hormone therapy | Treatment can alter bleeding and hormone measurements | Ask the prescriber how the regimen changes interpretation of bleeding; do not stop medication just to stage yourself without clinical guidance. |
| PCOS | Longstanding irregularity overlaps with the 60-day marker | STRAW bleeding criteria cannot be applied mechanically. Some evidence suggests later menopause in PCOS, but the transition is not well characterized. |
| Periods stopped or became markedly irregular before 40 | Routine perimenopause is not the only explanation | Seek evaluation for primary ovarian insufficiency and other causes. Current guidance requires clinical history and biochemical confirmation; pregnancy must be excluded. |
| Chemotherapy, radiation, or tamoxifen | Bleeding can return after prolonged amenorrhea, and markers can be distorted | Use an oncology-informed clinical assessment rather than a consumer timeline. |
| Chronic illness, major weight loss, or nutritional compromise | Illness-related amenorrhea can resemble the menopausal transition | Investigate the underlying cause instead of assuming ovarian aging. |
| Both ovaries removed | Menopause is surgically induced rather than a natural staged transition | Use a surgery-specific clinical pathway; there may be no natural perimenopause runway. |
STRAW+10 says women after hysterectomy or ablation cannot be staged by menstrual bleeding criteria and that one hormone sample may be ambiguous. Its bleeding criteria are not applicable to PCOS, and it describes cancer treatment, tamoxifen, medication, and chronic illness as situations that complicate staging.
For periods stopping before 40, current ASRM guidance says clinicians should consider and exclude primary ovarian insufficiency; diagnosis is not made from age and missed periods alone.
If you're in one of these groups, the honest answer to “how long does perimenopause last for me?” is that a website cannot stage you from your calendar.
That's not the same as having no options. It means your route runs through a clinician who can assess your history, treatment, symptoms, and selective testing together.
If you've had a hysterectomy but kept one or both ovaries, the ovaries can still age on their own schedule. You can still experience the transition. You just cannot date it by bleeding.
Do I have to wait it out, or can I get treated now?
No. You do not have to reach menopause before discussing treatment for disruptive symptoms. The Menopause Society lists hormone therapy, combined hormonal contraception when contraception is also needed, and a levonorgestrel IUD plus estrogen among options used during perimenopause; the right choice depends on symptoms, bleeding, pregnancy risk, medical history, and clinician judgment.
We put this section late on purpose. You came for a timeline, not a pitch. But it would be a strange kind of honesty to spend thousands of words explaining that this might run eight or nine years and then pretend your only option is to endure it.
“Aren't I too early for hormone therapy?”
This is the reason a lot of women postpone the conversation for years.
The Menopause Society says hormone therapy is effective for bothersome hot flashes and night sweats during perimenopause, although it may cause breakthrough bleeding while cycles continue. When contraception is needed, combined hormonal contraceptives are frequently used; another option is a levonorgestrel IUD plus estrogen.
Product labeling is indication-specific. Divigel's current FDA label is for moderate-to-severe vasomotor symptoms due to menopause; it does not create a separate perimenopause indication. Hers states directly on its current page that its HRT prescribing for perimenopausal symptoms is off-label and at a provider's discretion.
In February 2026, the FDA approved updated labeling for the first six menopausal hormone therapy products, including changes to boxed-warning language and timing considerations. That action applied to those six approved products; it did not automatically rewrite every estrogen label, create a new perimenopause indication, or erase the endometrial-cancer warning for systemic estrogen used without adequate endometrial protection in a woman with a uterus.
We cover that change in detail in HRT benefits and risks.
The honest limitation — read this before you click anything
Online menopause care cannot examine you, perform an ultrasound, or take an endometrial sample through a screen. Duration questions are exactly where that matters, because a changed cycle can be part of the transition while abnormal bleeding can need a different workup.
Depending on your age, bleeding pattern, and risk history, a clinician may recommend an in-person examination, pelvic ultrasound, or endometrial sampling before or alongside treatment. Midi says it can refer patients for in-person testing, but its virtual visit does not perform the procedure. Sesame offers in-person clinicians and imaging listings in participating markets, but availability and price vary by location.
If that's what you need first, start in person — through your own OB-GYN, primary care clinician, a local women's health clinic, or a marketplace such as Sesame where the needed service is actually available.
But here's the trade, and it's real. A telehealth service can get you to a clinician focused on midlife care without requiring every step to begin in the same building. For women whose main symptoms are hot flashes, night sweats, disrupted sleep, or vaginal dryness — and whose bleeding is changing rather than alarming — online care can be a practical place to begin.
If you have bleeding between periods, bleeding after sex, unusually heavy or prolonged bleeding, or any bleeding after 12 clear months, start with an in-person evaluation. Read how to get abnormal perimenopausal bleeding evaluated before choosing a platform. Please don't skip that one to save time.
Where women can actually start
| Provider | Best fit for | Care and medication model | Payment and program limits | Evidence status |
|---|---|---|---|---|
| Midi Health | Insurance-first virtual midlife care; nationwide access; can order tests and refer for in-person workup | Its standard HRT service prescribes commercially available, FDA-approved products when appropriate. Its separate Custom Rx service uses compounded medications, which are not FDA-approved and are cash-pay. | In-network with most PPO plans; coverage varies. Self-pay visits are $250 initial / $150 follow-up. Midi cannot treat Medicaid or Medi-Cal patients, even self-pay. Medicare is not covered, but Medicare beneficiaries may use self-pay and cannot submit related claims. | Provider-stated; public pages rechecked August 3, 2026 |
| Sesame Care | Cash-pay marketplace for women who may need a virtual or local in-person clinician; imaging appears in participating markets | Treatment and medication choices vary by independent clinician. Sesame itself is a marketplace, not the treating provider. | Cash-pay; Sesame does not accept insurance for provider visits or medications. Its terms require users to certify they are not Medicare, Medicaid, or TRICARE beneficiaries. In-person availability and prices vary by provider and market. | Provider-stated; public terms and service pages rechecked August 3, 2026 |
| Hers | Straightforward, fully online cash-pay assessment where available | Offers access to estradiol pills or patches, estradiol vaginal cream, and oral progesterone when prescribed. Hers states that HRT for perimenopausal symptoms is prescribed off-label at provider discretion. | Cash-pay and not available in all 50 states. Confirm eligibility, exact plan contents, and current price during assessment before paying. | Provider-stated; public pages rechecked August 3, 2026 |
“Provider-stated” means the provider publishes the fact. “Rechecked” means The HRT Index reopened the current primary pages on August 3, 2026 and confirmed the public wording; it does not mean we independently tested service delivery.
FDA-approved and compounded medications are not interchangeable labels. Compounded drugs are prepared by compounding pharmacies and are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before marketing.
Medicare and Medicaid are not one bucket: Midi cannot treat Medicaid or Medi-Cal patients but can accept Medicare beneficiaries on a self-pay, no-claims basis. Sesame's terms require users to certify that they are not Medicare, Medicaid, or TRICARE beneficiaries. Hers' perimenopause program is cash-pay and not available in all 50 states; its public program page does not describe Medicare or Medicaid billing, so confirm eligibility before paying.
### Check whether Midi fits your insurance and state. Does this sound like your situation — symptoms you're tired of waiting out, no red-flag bleeding, and a preference for insurance-first virtual care? Check Midi's current coverage and visit cost for your state → We may earn a commission if you book through this link. It does not change what we publish — see our affiliate disclosure.
Can I still get pregnant during perimenopause?
Yes. Ovulatory cycles become less common as the final period approaches, but they can still occur unpredictably. In the evidence summarized by Harlow, 22.8% of cycles within one year of the final menstrual period were ovulatory; federal guidance says to continue contraception until one full year after the last period if pregnancy is possible and undesired.
The research is specific on this. Ovulatory cycles become less frequent, but they can continue through the end of reproductive life, with the accompanying risk of unintended pregnancy.
A skipped period is not a green light. A 60-day interval is not a green light. Twelve clear months is the current U.S. federal line for confirming menopause when natural bleeding can be tracked.
The Office on Women's Health puts it plainly: pregnancy is still possible during perimenopause even after missing one or several periods, because ovulation may still happen and there is no way to know which month it will occur.
One useful overlap: some contraceptive options can also manage perimenopausal symptoms. That is why “birth control or hormone therapy?” is a genuine clinical fork, not a trick question.
What if it isn't perimenopause?
Several conditions can overlap with fatigue, cycle changes, temperature intolerance, mood symptoms, sleep disruption, and brain fog. Thyroid disease is one important overlap; pregnancy, iron deficiency, medication effects, sleep disorders, and other causes can also coexist with perimenopause rather than neatly replacing it.
This is the fear underneath the searching for a lot of women. So let's name it.
Being 45 with irregular periods does not make every new symptom hormonal. It is possible to be in the menopausal transition and have another condition making the experience worse.
| Overlap worth considering | Why it can look similar | What changes the next step |
|---|---|---|
| Pregnancy | Missed periods, breast changes, fatigue, nausea | Pregnancy testing when relevant; do not assume a missed period is perimenopause |
| Thyroid disease | Cycle changes, fatigue, temperature intolerance, mood or weight changes | Clinical assessment and thyroid testing when indicated |
| Iron deficiency or anemia | Exhaustion, weakness, breathlessness, palpitations, headaches | Bleeding history and blood testing when indicated |
| Sleep apnea or another sleep disorder | Broken sleep, fatigue, mood and cognitive symptoms | Sleep-focused assessment rather than treating every symptom as hormonal |
| Medication effects | Bleeding changes, sweating, sleep or mood symptoms | Medication review before adding or changing treatment |
| Primary ovarian insufficiency before 40 | Irregular or absent periods and estrogen-deficiency symptoms | Dedicated clinical evaluation and biochemical confirmation under current guidance |
Pregnancy and hormone-testing limits are covered by federal menopause guidance; thyroid-cycle effects, iron-deficiency symptoms, sleep-related fatigue and cognitive effects, and POI criteria were checked against current federal or specialty guidance.
We're not going to hand you a universal list of labs to demand. That is individual medical judgment and depends on your age, history, symptoms, medications, and bleeding pattern.
But here's a useful rule: symptoms that do not fit your cycle pattern, are new or severe, or do not improve as expected deserve a broader look. If your periods have stayed regular but you feel wrecked, investigation is more useful than filing everything under “hormones.”
If you're not yet sure whether the symptoms you're having belong in this picture, start with our perimenopause symptoms checklist. For the terminology itself, see perimenopause vs menopause.
What we actually verified
We verified the duration ranges, stage markers, symptom timelines, testing limits, bleeding red flags, FDA labeling change, treatment options, and every provider fact in the table against primary or authoritative sources current on August 3, 2026. We did not verify — and do not claim — an exact personal end date, a diagnosis, or that one symptom trajectory applies to every woman.
We think you should be able to check our work. Here's exactly what we did.
Medical and research claims
- Federal duration, age, testing, contraception, and postmenopausal-bleeding guidance — Office on Women's Health, updated April 2, 2026.
- Early and late stage criteria, the one-to-three-year late-stage estimate, biomarker limits, and the broader definition ending 12 months after the final period — full STRAW+10 executive summary.
- Marker-to-final-period medians, minimal-change patterns, ovulation data, late-bleed statistic, and the six-subgroup analysis — Harlow's 2018 review, read in full.
- Transition duration by age at onset — Paramsothy et al., SWAN cohort.
- Frequent hot-flash and night-sweat duration — Avis et al., SWAN cohort.
- Perimenopausal treatment options — The Menopause Society patient guidance.
- Primary ovarian insufficiency language and current diagnostic framework — ASRM's current evidence-based guideline.
- Bleeding patterns that warrant review — Mayo Clinic and the Office on Women's Health.
- 2026 menopausal hormone therapy label changes — FDA announcement and current product labeling.
Provider and commercial facts
- Midi Health — insurance restrictions, Medicare and Medicaid rules, self-pay visit prices, testing/referral claims, and the separate compounded Custom Rx service checked on Midi's current pages.
- Sesame Care — cash-pay terms, federal-program beneficiary restriction, marketplace status, and variable in-person and imaging availability checked on Sesame's current terms and service pages.
- Hers — state limitation, cash-pay model, offered medication routes, prescription requirement, and provider-stated off-label perimenopause language checked on Hers' current perimenopause pages.
How we review providers
The HRT Index Verification Standard is our documented process: we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, the full roster quarterly.
We evaluate providers on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, access.
We do not publish numeric scores. One number would hide the exact trade-offs you need to see.
Who wrote this
The HRT Index Editorial Team. This page is editorial research and has not been reviewed by a clinician — see our medical review policy and editorial standards.
Found an error? Tell us. We publish corrections.
Frequently asked questions
How long does perimenopause last on average?
About four years before periods stop for most women, with a federal range of two to eight years under current Office on Women's Health guidance. Menopause is confirmed after 12 months without bleeding or spotting; STRAW+10's broad use of “perimenopause” includes that confirmation year.
Can perimenopause last 10 years?
Yes. Longitudinal evidence describes nonsudden transitions of roughly four to 10 years, and three early-starting groups in a reanalysis averaged nine to 11 years. A long transition does not mean every symptom will remain severe or continuous for a decade.
What's the shortest perimenopause can be?
There is no validated personal minimum that lets a website promise “this was only three months.” Some women have little or no obvious cycle change before the final period, and a review found roughly 12% to 25% had minimal or no cycle-length warning. Surgical or treatment-induced menopause is a separate pathway, not simply a short natural perimenopause.
How do I know whether I'm at the beginning or the end?
Use cycle patterns more than symptoms. A persistent difference of seven or more days between consecutive cycle lengths marks early transition; a period-free interval of 60 days or more marks late transition. After age 40, the median times from those markers to the final period were five to eight years and about 2.5 to 3 years, respectively.
Does perimenopause end when my periods stop?
It depends on the definition being used. The Office on Women's Health calls perimenopause the transition leading up to the final period. STRAW+10's broader common usage ends 12 months after that period, when menopause can be confirmed. That one-year definition gap explains part of the disagreement between sources.
What is the average age of menopause?
The average U.S. age is 52, with a usual range of 45 to 58 under current Office on Women's Health guidance.
How long do hot flashes last after the final period?
Among women with frequent hot flashes or night sweats in SWAN, the median persistence after the final period was 4.5 years. In the subgroup whose frequent symptoms began before cycle changes or during early transition, the median post-final-period persistence was 9.4 years. These are group estimates for frequent vasomotor symptoms, not every woman or every symptom.
Can a blood test tell me how much longer perimenopause will last?
No single FSH or estradiol result can produce a reliable personal countdown. Hormone levels fluctuate, and a 60-day period-free interval predicted proximity to the final period better than one early-follicular FSH result in two longitudinal studies.
Does starting early mean a longer perimenopause?
At the group level, yes. In SWAN, the adjusted median was 8.57 years in the youngest age-at-onset quartile and 4.37 years in the oldest. That almost twofold difference is strong context, not a personal forecast.
How long does perimenopause last after a hysterectomy?
There is no reliable bleeding-based answer. STRAW+10 says women after hysterectomy or endometrial ablation cannot be staged with menstrual criteria. If one or both ovaries remain, ovarian aging can continue, but clinical history and supportive criteria are needed instead of period counting.
Does spotting reset the 12-month menopause clock?
Yes. Menopause requires 12 consecutive months with no bleeding, including spotting. Any bleeding before that mark means the confirmation interval begins again from the most recent bleeding; any bleeding after menopause is confirmed should be evaluated promptly.
Can I still get pregnant during perimenopause?
Yes. Ovulation can still occur unpredictably, even after skipped months. If pregnancy is possible and undesired, current U.S. federal guidance says to continue contraception until one full year after the last period and discuss your individual needs with a clinician.
Do I have to wait until menopause to discuss hormone therapy?
No. The Menopause Society describes hormone therapy, combined hormonal contraception, and a levonorgestrel IUD plus estrogen as options used during perimenopause depending on symptoms and contraception needs. Product labeling is indication-specific: Divigel's current FDA label is for moderate-to-severe vasomotor symptoms due to menopause, and Hers explicitly states that its perimenopause prescribing is provider-directed and off-label.
What if my periods stop before age 40?
Do not assume routine perimenopause. Current ASRM guidance says clinicians should consider and exclude primary ovarian insufficiency in women under 40 with amenorrhea, irregular cycles, or estrogen-deficiency symptoms; pregnancy and other causes also need consideration.
Still not sure which HRT program is right for you?
You now know the honest average, which stage marker matters, why the published numbers disagree, and why the symptom clock may outlast the period clock.
What you do with that depends on things no article can see: your symptoms, your bleeding pattern, your history, your insurance, your state, and whether online care is even the right place to start.
Take Find My HRT Path — about 90 seconds, no email →
It matches your situation to the right kind of care and flags when you should be seen in person first.
And if you take one thing from this page: you don't have to wait for perimenopause to end before asking for help with it.
The HRT Index is not a medical provider. This page is educational and is not medical advice. Talk with a qualified clinician about your individual situation, especially any bleeding that is new, heavy, prolonged, between periods, after sex, or after 12 months without bleeding.